Developer docs
API playgroundTry for free, no card

Search company profiles

Biologix

Full company profile

uuid0003e7e

Namestring
Biologix
Legal namestring
Biologix Sistemas S.A.
Websiteurl
biologix.com.br
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Biologix (legally Biologix Sistemas S.A.) is a São Paulo-based medical technology company that operates a multimodal home polysomnography platform for diagnosing obstructive sleep apnea. The platform combines two proprietary hardware sensors — the Oxistar 2 finger-worn high-resolution oximetry sensor and the optional Bodystar body position sensor — with a smartphone application and a cloud-based professional portal. During a sleep exam, the system records four simultaneous channels: peripheral oxygen saturation (SpO2), heart rate, hand actigraphy, and snoring via the phone microphone, and applies a proprietary AI algorithm to estimate total sleep time, classify sleep stages (Light, Deep, REM), analyze heart rate variability, and compute the Oxygen Desaturation Index adjusted to estimated sleep time (ODI Sono). The algorithm has been peer-reviewed in Scientific Reports (Nature) in 2024, and the Oxistar sensor stores personal data with AES-128 encryption under an LGPD-compliant privacy policy. The company was founded in 2015 by electrical engineer Tácito de Almeida and pulmonologist Dr. Geraldo Lorenzi Filho of InCor/HCFMUSP.

The flagship product, the Biologix Sleep Test (Exame do Sono Biologix), is delivered through a network of more than 9,000 accredited diagnostic centers across Latin America with localized country portals for Brazil and Chile. Complementary offerings include the Biologix Snoring Test (Teste do Ronco) for app-only self-screening without sensors, the Laudo Automatizado for automated specialist-signed report generation, the Biologix Academy education program, and the Biologix Portal with Patient Records (Prontuários) and CPAP Indication (Indicação de CPAP) workflows for prescribing professionals. Cumulative volume exceeds 600,000 home sleep exams across Latin America at a current run-rate above 21,000 exams per month, with the company citing +90% accuracy in OSA diagnosis versus clinical studies.

Biologix generates revenue through a combination of hardware sales or loaners of Oxistar 2 and Bodystar sensors, per-exam diagnostic fees paid by accredited centers for each Biologix Sleep Test processed through the cloud portal, subscription or active-plan fees for prescribing professionals accessing premium portal features, and distributor or wholesale revenue in Latam markets. The company was founded in 2015, received two FAPESP PIPE Phase III grants plus investment from Hospital Israelita Albert Einstein and a physician group in 2019, and added a $1.2M round in May 2024 led by Hospital Israelita Albert Einstein and Kortex Ventures. Pricing is quote-based and not publicly listed, with intake routed through a "Quero ser um Centro Credenciado" consultant funnel across categories including sleep medicine, ENT, cardiology, pulmonology, neurology, dentistry, and health plans.

Short descriptiontext

Biologix is a São Paulo-based medical technology company that operates a multimodal home sleep apnea diagnostic platform combining proprietary Oxistar 2 and Bodystar sensors with an AI-driven cloud portal used by 9,000+ accredited diagnostic centers across Latin America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home sleep diagnostics, sleep apnea testing, medical sensor devices, digital health platform, polysomnography solutions
Industry2 codes
PRIMARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Home Sleep Diagnostics
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hardware sales — Oxistar® 2 and Bodystar® sensors
TypeHardware Sales
Description

Sale/loaner distribution of proprietary finger oximetry (Oxistar 2) and position (Bodystar) sensors used by accredited centers and patients to perform the home sleep exam. Product is shipped/handed to patients via Centros Credenciados and recovered after the exam.

biologix.com.br:443
2Per-exam diagnostic service for accredited centers
TypeUsage Based
Description

Centros Credenciados (clinics, physician offices, sleep labs) purchase access to the Biologix platform and pay for each Biologix Sleep Test (Exame do Sono Biologix®) and Laudo Automatizado processed via the cloud portal. Usage-based revenue tied to the volume of home polysomnography exams performed.

biologix.com.br:443
3Subscription / portal plans for prescribing professionals
TypeSubscription Recurring
Description

Active plans for prescribing healthcare professionals (e.g., physicians/dentists) unlocking portal features such as Prontuários and the CPAP Indicação workflow. Recurring SaaS-style revenue layered on top of per-exam fees.

biologix.com.br:443
4Distributor / channel revenue
TypeOthers
Description

Indirect distribution via "Distribuidores" partners in Brazil and Latam (separate country portals such as portal.biologix.cl for Chile) generate wholesale/buy-and-resell revenue.

biologix.com.br:443
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details2 tiers
1Quote-based — not publicly listed; requires contacting a Biologix consultant to credential the practice/center
ModelOtherBilling cadencePay-as-you-go
Notes

Exam and sensor pricing obtained via sales consultant after category selection; revenue tied to per-exam usage at accredited centers.

biologix.com.br:443
2Active-plan tier for prescribing professionals
ModelSubscriptionBilling cadenceAnnual
Notes

Subscription/active plan required to access Prontuários and the Indicação de CPAP workflow inside the Biologix Portal.

biologix.com.br:443
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1Oxistar
Description

Finger-worn oximetry sensor used for at-home sleep apnea diagnosis; current generation is Oxistar 2 with high-resolution oximetry, USB-C charging, sleep stage classification, and heart rate variability analysis.

biologix.com.br:443
+4 more records
Core offering1 text field

Biologix operates a vertically integrated home sleep apnea diagnostics platform that combines proprietary medical hardware (Oxistar® 2 finger oximetry sensor and Bodystar® body position sensor), a patient-facing mobile app, and a cloud-based clinician portal. The flagship Biologix Sleep Test (Exame do Sono Biologix®) is a multimodal home polysomnography that fuses SpO2, heart rate, actigraphy, and snoring into an AI-driven report (Laudo Automatizado), delivered through a network of 9,000+ accredited diagnostic centers across Latin America.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • +90% accuracy in obstructive sleep apnea diagnosis, per clinical studies
+4 more records
Product overview1 text field

Biologix (operated by Biologix Sistemas S.A.) is a vertically integrated sleep apnea diagnostic platform that combines proprietary medical hardware with cloud software. The hardware layer consists of the Oxistar 2 high-resolution finger oximetry sensor and the Bodystar body position sensor. The software layer is the Biologix mobile app (iOS/Android) for patients and the Biologix Portal for accredited healthcare professionals. The flagship offering, the Biologix Sleep Test (Exame do Sono Biologix), is a multimodal home polysomnography that fuses oximetry, heart rate, actigraphy, and snoring (via the smartphone microphone) and uses AI to estimate sleep, classify stages (Light, Deep, REM), analyze HRV, and produce an automated report (Laudo Automatizado) signed by sleep specialists. Complementary offerings include the Biologix Snoring Test (app-only snoring screening) and the Biologix Academy education program for healthcare practitioners. The platform is delivered through a network of 9,000+ accredited diagnostic centers across Latin America, which together have performed more than 600,000 exams.

Product and service8 records
1Oxistar 2
CategoryHardware sensor (finger oximeter)
Description

High-resolution finger-worn oximetry sensor that captures peripheral oxygen saturation (SpO2) and heart rate during sleep, with on-device AI that classifies sleep phases (Light, Deep, REM), analyzes heart rate variability (HRV), and provides up to 30 hours of continuous monitoring on a single USB-C charge. Sold/loaned to accredited centers for the Biologix Sleep Test.

2Bodystar
CategoryHardware sensor (body position)
Description

Wearable body position sensor that pairs with the Oxistar sensor and the Biologix app to correlate oxygen desaturations and snoring intensity with supine, prone, and right/left side-sleeping positions for the diagnosis of positional sleep apnea, with up to 60 hours of battery and 1.5-hour fast charging.

3Biologix Sleep Test (Exame do Sono Biologix)
CategoryHome multimodal polysomnography (diagnostic service)
Description

Flagship home sleep apnea test combining the Oxistar sensor, the Bodystar sensor, and the Biologix app to deliver a multimodal polysomnography (oximetry, heart rate, actigraphy, snoring) at home, with AI-driven sleep estimation and a report available in minutes on the Biologix Portal. Purchased per-exam by accredited diagnostic centers.

4Biologix Snoring Test (Teste do Ronco Biologix)
CategoryApp-based snoring screening test
Description

Smart screening test that captures and analyzes patients' snoring patterns using only the Biologix mobile app and the smartphone microphone, with no sensor hardware required; designed to triage snoring patterns and feed the broader Biologix diagnostic workflow.

5Biologix Mobile App
CategoryMobile application (iOS and Android)
Description

Consumer mobile app (iOS and Android) that pairs with Oxistar and Bodystar sensors, runs the Biologix Sleep Test and Biologix Snoring Test, uploads data to the Biologix platform, and delivers test results to patients.

6Biologix Portal (Portal Biologix)
CategoryWeb platform for healthcare professionals
Description

Web portal for accredited diagnostic centers and prescribing clinicians to receive Biologix test results, manage patient records (Prontuários), and record CPAP treatment indications to support continuity of care after an OSA diagnosis. Available via subscription/active plan for prescribing professionals.

7Biologix Academy
CategoryEducation / training program
Description

Educational initiative led by Dr. George Pinheiro (Head of Teaching) covering sleep apnea diagnosis, polysomnography, and use of the Biologix platform for healthcare practitioners.

8Laudo Automatizado (Automated Report)
CategoryAutomated diagnostic report service
Description

Automated high-fidelity diagnostic report generated in minutes after a Biologix Sleep Test, then signed by accredited sleep specialists and made available on the Biologix Portal for healthcare practitioners.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinor — Co-Appointment SignalTypeGTM or Marketing PartnerAnnounced on2026-02-09
Description

Joëlle Massaad was appointed as Head of People & Culture at Algorithm Pharmaceutical Manufacturers & Biologix in Beirut, Lebanon. She will oversee talent strategy, organizational effectiveness, and cultural transformation at both companies, signaling a cross-company people-ops alliance between the two firms.

2InCor – Instituto do Coração, Hospital das Clínicas da FMUSP (Sleep Lab directed by Dr. Geraldo Lorenzi Filho)
Strategic tierFlagship Clinical / Scientific PartnerTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Dr. Geraldo Lorenzi Filho is a Biologix member and Director of the Sleep Lab at InCor/HCFMUSP. He provided the scientific co-development expertise behind the platform and presented Biologix telemonitoring data at a Resmed congress as a case study.

biologix.com.br
3Hospital for Rehabilitation of Craniofacial Anomalies (HRAC), University of São Paulo – Bauru
Strategic tierCore Academic PartnerTypeStrategic or Co-development Partner
Description

Research/clinical affiliate — Dr. Walter Silva Júnior is certified by the American Board of Dental Sleep Medicine and holds a Ph.D. in Sleep Medicine from HRAC/USP-Bauru; he authors educational content for the Biologix platform and is featured as a key opinion leader.

biologix.com.br
Strategic tierStandard Distribution ChannelTypeTechnology or Integration
Description

Biologix Pro mobile application is distributed via the Apple App Store under app id6449978430.

Strategic tierStandard Distribution ChannelTypeTechnology or Integration
Description

Biologix Pro mobile application is distributed via Google Play under package br.com.biologix.pro.

6Latam country distributors (e.g., Chile via portal.biologix.cl)
Strategic tierCore Regional ChannelTypeChannel Partner/ Reseller/ Distributor
Description

Biologix operates a "Distribuidores" program with country-specific portals (e.g., portal.biologix.cl for Chile) to resell sensors and platform access in Spanish-speaking Latin America. The Spanish-language site is targeted at this distributor channel.

biologix.com.br:443
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in sleep-disordered breathing and CPAP therapy with home sleep testing diagnostics (e.g., ApneaLink Air) used by the same physician specialties Biologix targets. Comparable as the dominant incumbent whose devices, installed CPAP base, and global distribution Biologix competes against in Latam.

TypeBroad incumbent
Description

Markets the Alice NightOne home sleep testing device and a full sleep-care portfolio (CPAP, ventilators, clinical software). Directly comparable as a global incumbent competing in the same home-sleep-diagnostic category with substantially larger R&D and commercial resources.

TypeDirect peer
Description

WatchPAT is a wrist-worn home sleep apnea diagnostic using peripheral arterial tone plus oximetry/actigraphy — the same physiological-signal approach Biologix uses, sold to similar cardiology and sleep-medicine specialists. Closest direct competitor in the home-multimodal-HST category.

TypeDirect peer
Description

Provides Nox T3 and other Type III portable polysomnography systems plus cloud analysis software (Noxturnal) sold to sleep labs and clinicians. Comparable to Biologix as a focused sleep-diagnostic hardware-and-software vendor competing for the same home/ambulatory PSG use case.

TypeDirect peer
Description

Australasian sleep-diagnostics and neurology company offering Somfit, Somte, and Profusion polysomnography platforms. Comparable as a dedicated sleep/neuro diagnostics vendor with both hardware sensors and cloud-style analysis software, similar in product mix to Biologix.

TypeDirect peer
Description

US-based maker of the SleepView and Sapphire PSG home sleep testing devices with cloud review software. Comparable to Biologix as a focused home-sleep-diagnostic hardware-plus-cloud-software vendor serving the same physician specialties.

TypeDirect peer
Description

German manufacturer of home/ambulatory polysomnography systems (SOMNOwatch, SOMNOscreen) used by sleep specialists and researchers. Comparable to Biologix in the home-multimodal-PSG category with proprietary hardware and analysis software.

TypeRegional player
Description

Chinese sleep-and-respiratory vendor selling home sleep testing devices, CPAP, and ventilators across Asia and emerging markets. Comparable to Biologix as a regional incumbent pushing into price-sensitive markets with bundled sleep-care hardware.

9Apex Medical
TypeRegional player
Description

Taiwan-based sleep-and-respiratory manufacturer offering home sleep testing devices alongside CPAP/BPAP. Comparable to Biologix as an Asia-rooted competitor with multi-channel GTM in emerging markets that could overlap with Latam expansion.

TypeDirect peer
Description

US neurodiagnostics and sleep company selling PSG hardware and cloud review software to sleep labs and clinicians. Comparable to Biologix as a specialist sleep/neurodiagnostics vendor combining proprietary sensors with cloud analytics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biologix

Home Sleep Diagnosticsbiologix.com.br

Biologix is a São Paulo-based medical technology company that operates a multimodal home sleep apnea diagnostic platform combining proprietary Oxistar 2 and Bodystar sensors with an AI-driven cloud portal used by 9,000+ accredited diagnostic centers across Latin America.

What Biologix does

Biologix (legally Biologix Sistemas S.A.) is a São Paulo-based medical technology company that operates a multimodal home polysomnography platform for diagnosing obstructive sleep apnea. The platform combines two proprietary hardware sensors — the Oxistar 2 finger-worn high-resolution oximetry sensor and the optional Bodystar body position sensor — with a smartphone application and a cloud-based professional portal. During a sleep exam, the system records four simultaneous channels: peripheral oxygen saturation (SpO2), heart rate, hand actigraphy, and snoring via the phone microphone, and applies a proprietary AI algorithm to estimate total sleep time, classify sleep stages (Light, Deep, REM), analyze heart rate variability, and compute the Oxygen Desaturation Index adjusted to estimated sleep time (ODI Sono). The algorithm has been peer-reviewed in Scientific Reports (Nature) in 2024, and the Oxistar sensor stores personal data with AES-128 encryption under an LGPD-compliant privacy policy. The company was founded in 2015 by electrical engineer Tácito de Almeida and pulmonologist Dr. Geraldo Lorenzi Filho of InCor/HCFMUSP.

The flagship product, the Biologix Sleep Test (Exame do Sono Biologix), is delivered through a network of more than 9,000 accredited diagnostic centers across Latin America with localized country portals for Brazil and Chile. Complementary offerings include the Biologix Snoring Test (Teste do Ronco) for app-only self-screening without sensors, the Laudo Automatizado for automated specialist-signed report generation, the Biologix Academy education program, and the Biologix Portal with Patient Records (Prontuários) and CPAP Indication (Indicação de CPAP) workflows for prescribing professionals. Cumulative volume exceeds 600,000 home sleep exams across Latin America at a current run-rate above 21,000 exams per month, with the company citing +90% accuracy in OSA diagnosis versus clinical studies.

Biologix generates revenue through a combination of hardware sales or loaners of Oxistar 2 and Bodystar sensors, per-exam diagnostic fees paid by accredited centers for each Biologix Sleep Test processed through the cloud portal, subscription or active-plan fees for prescribing professionals accessing premium portal features, and distributor or wholesale revenue in Latam markets. The company was founded in 2015, received two FAPESP PIPE Phase III grants plus investment from Hospital Israelita Albert Einstein and a physician group in 2019, and added a $1.2M round in May 2024 led by Hospital Israelita Albert Einstein and Kortex Ventures. Pricing is quote-based and not publicly listed, with intake routed through a "Quero ser um Centro Credenciado" consultant funnel across categories including sleep medicine, ENT, cardiology, pulmonology, neurology, dentistry, and health plans.

Biologix firmographics

Firmographics
Name
Biologix
Legal name
Biologix Sistemas S.A.
Website
https://biologix.com.br
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Biologix is a São Paulo-based medical technology company that operates a multimodal home sleep apnea diagnostic platform combining proprietary Oxistar 2 and Bodystar sensors with an AI-driven cloud portal used by 9,000+ accredited diagnostic centers across Latin America.
Ownership category
akta.pro rank

Biologix industry classification

Industry
Product category
Home Sleep Diagnostics
NAICS
Medical and Diagnostic Laboratories (6215), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAFAB
Respiratory & Sleep RPM (COPD, asthma, sleep apnea)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Home sleep diagnostics
  • Sleep apnea testing
  • Medical sensor devices
  • Digital health platform
  • Polysomnography solutions

Where Biologix is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Biologix business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Hardware sales — Oxistar® 2 and Bodystar® sensors: Sale/loaner distribution of proprietary finger oximetry (Oxistar 2) and position (Bodystar) sensors used by accredited centers and patients to perform the home sleep exam. Product is shipped/handed to patients via Centros Credenciados and recovered after the exam.
  2. Per-exam diagnostic service for accredited centers: Centros Credenciados (clinics, physician offices, sleep labs) purchase access to the Biologix platform and pay for each Biologix Sleep Test (Exame do Sono Biologix®) and Laudo Automatizado processed via the cloud portal. Usage-based revenue tied to the volume of home polysomnography exams performed.
  3. Subscription / portal plans for prescribing professionals: Active plans for prescribing healthcare professionals (e.g., physicians/dentists) unlocking portal features such as Prontuários and the CPAP Indicação workflow. Recurring SaaS-style revenue layered on top of per-exam fees.
  4. Distributor / channel revenue: Indirect distribution via "Distribuidores" partners in Brazil and Latam (separate country portals such as portal.biologix.cl for Chile) generate wholesale/buy-and-resell revenue.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based — not publicly listed; requires contacting a Biologix consultant to credential the practice/center
SubscriptionAnnualActive-plan tier for prescribing professionals

Go-to-market motion5 records

Distribution channels5 records

Marketing channels9 records

Biologix product offering

Product offering

Core offering

Biologix operates a vertically integrated home sleep apnea diagnostics platform that combines proprietary medical hardware (Oxistar® 2 finger oximetry sensor and Bodystar® body position sensor), a patient-facing mobile app, and a cloud-based clinician portal. The flagship Biologix Sleep Test (Exame do Sono Biologix®) is a multimodal home polysomnography that fuses SpO2, heart rate, actigraphy, and snoring into an AI-driven report (Laudo Automatizado), delivered through a network of 9,000+ accredited diagnostic centers across Latin America.

Product overview

Biologix (operated by Biologix Sistemas S.A.) is a vertically integrated sleep apnea diagnostic platform that combines proprietary medical hardware with cloud software. The hardware layer consists of the Oxistar 2 high-resolution finger oximetry sensor and the Bodystar body position sensor. The software layer is the Biologix mobile app (iOS/Android) for patients and the Biologix Portal for accredited healthcare professionals. The flagship offering, the Biologix Sleep Test (Exame do Sono Biologix), is a multimodal home polysomnography that fuses oximetry, heart rate, actigraphy, and snoring (via the smartphone microphone) and uses AI to estimate sleep, classify stages (Light, Deep, REM), analyze HRV, and produce an automated report (Laudo Automatizado) signed by sleep specialists. Complementary offerings include the Biologix Snoring Test (app-only snoring screening) and the Biologix Academy education program for healthcare practitioners. The platform is delivered through a network of 9,000+ accredited diagnostic centers across Latin America, which together have performed more than 600,000 exams.

Differentiator

Problem solved

Functional benefit

Brands

  • Oxistar: Finger-worn oximetry sensor used for at-home sleep apnea diagnosis; current generation is Oxistar 2 with high-resolution oximetry, USB-C charging, sleep stage classification, and heart rate variability analysis.
  • Bodystar
  • Biologix® Sleep Test (Exame do Sono Biologix®)
  • Teste do Ronco Biologix® (Biologix Snoring Test)
  • Biologix Academy

Products and services

  • Oxistar 2 High-resolution finger-worn oximetry sensor that captures peripheral oxygen saturation (SpO2) and heart rate during sleep, with on-device AI that classifies sleep phases (Light, Deep, REM), analyzes heart rate variability (HRV), and provides up to 30 hours of continuous monitoring on a single USB-C charge. Sold/loaned to accredited centers for the Biologix Sleep Test.
  • Bodystar Wearable body position sensor that pairs with the Oxistar sensor and the Biologix app to correlate oxygen desaturations and snoring intensity with supine, prone, and right/left side-sleeping positions for the diagnosis of positional sleep apnea, with up to 60 hours of battery and 1.5-hour fast charging.
  • Biologix Sleep Test (Exame do Sono Biologix) Flagship home sleep apnea test combining the Oxistar sensor, the Bodystar sensor, and the Biologix app to deliver a multimodal polysomnography (oximetry, heart rate, actigraphy, snoring) at home, with AI-driven sleep estimation and a report available in minutes on the Biologix Portal. Purchased per-exam by accredited diagnostic centers.
  • Biologix Snoring Test (Teste do Ronco Biologix) Smart screening test that captures and analyzes patients' snoring patterns using only the Biologix mobile app and the smartphone microphone, with no sensor hardware required; designed to triage snoring patterns and feed the broader Biologix diagnostic workflow.
  • Biologix Mobile App Consumer mobile app (iOS and Android) that pairs with Oxistar and Bodystar sensors, runs the Biologix Sleep Test and Biologix Snoring Test, uploads data to the Biologix platform, and delivers test results to patients.
  • Biologix Portal (Portal Biologix) Web portal for accredited diagnostic centers and prescribing clinicians to receive Biologix test results, manage patient records (Prontuários), and record CPAP treatment indications to support continuity of care after an OSA diagnosis. Available via subscription/active plan for prescribing professionals.
  • Biologix Academy Educational initiative led by Dr. George Pinheiro (Head of Teaching) covering sleep apnea diagnosis, polysomnography, and use of the Biologix platform for healthcare practitioners.
  • Laudo Automatizado (Automated Report) Automated high-fidelity diagnostic report generated in minutes after a Biologix Sleep Test, then signed by accredited sleep specialists and made available on the Biologix Portal for healthcare practitioners.

Quantifiable outcome

  • +90% accuracy in obstructive sleep apnea diagnosis, per clinical studies
  • +4 more outcomes

Companies that use Biologix

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Biologix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature8 records

Biologix partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor — co-appointment signal, flagship clinical / scientific partner, core academic partner, standard distribution channel and core regional channel.

  • Algorithm Pharmaceutical Manufacturersminor — co-appointment signalGTM or Marketing Partner · 9 February 2026Joëlle Massaad was appointed as Head of People & Culture at Algorithm Pharmaceutical Manufacturers & Biologix in Beirut, Lebanon. She will oversee talent strategy, organizational effectiveness, and cultural transformation at both companies, signaling a cross-company people-ops alliance between the two firms.
  • InCor – Instituto do Coração, Hospital das Clínicas da FMUSP (Sleep Lab directed by Dr. Geraldo Lorenzi Filho)flagship clinical / scientific partnerStrategic or Co-development Partner · 1 January 2020Dr. Geraldo Lorenzi Filho is a Biologix member and Director of the Sleep Lab at InCor/HCFMUSP. He provided the scientific co-development expertise behind the platform and presented Biologix telemonitoring data at a Resmed congress as a case study.
  • Hospital for Rehabilitation of Craniofacial Anomalies (HRAC), University of São Paulo – Baurucore academic partnerStrategic or Co-development PartnerResearch/clinical affiliate — Dr. Walter Silva Júnior is certified by the American Board of Dental Sleep Medicine and holds a Ph.D. in Sleep Medicine from HRAC/USP-Bauru; he authors educational content for the Biologix platform and is featured as a key opinion leader.
  • Apple App Storestandard distribution channelTechnology or IntegrationBiologix Pro mobile application is distributed via the Apple App Store under app id6449978430.
  • Google Playstandard distribution channelTechnology or IntegrationBiologix Pro mobile application is distributed via Google Play under package br.com.biologix.pro.
  • Latam country distributors (e.g., Chile via portal.biologix.cl)core regional channelChannel Partner/ Reseller/ DistributorBiologix operates a "Distribuidores" program with country-specific portals (e.g., portal.biologix.cl for Chile) to resell sensors and platform access in Spanish-speaking Latin America. The Spanish-language site is targeted at this distributor channel.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Biologix competitors and assessment

Company assessment

Broad incumbents

  • Resmed: Global leader in sleep-disordered breathing and CPAP therapy with home sleep testing diagnostics (e.g., ApneaLink Air) used by the same physician specialties Biologix targets. Comparable as the dominant incumbent whose devices, installed CPAP base, and global distribution Biologix competes against in Latam.
  • Philips (Respironics): Markets the Alice NightOne home sleep testing device and a full sleep-care portfolio (CPAP, ventilators, clinical software). Directly comparable as a global incumbent competing in the same home-sleep-diagnostic category with substantially larger R&D and commercial resources.

Direct peers

  • Itamar Medical (ZOLL Itamar): WatchPAT is a wrist-worn home sleep apnea diagnostic using peripheral arterial tone plus oximetry/actigraphy — the same physiological-signal approach Biologix uses, sold to similar cardiology and sleep-medicine specialists. Closest direct competitor in the home-multimodal-HST category.
  • Nox Medical: Provides Nox T3 and other Type III portable polysomnography systems plus cloud analysis software (Noxturnal) sold to sleep labs and clinicians. Comparable to Biologix as a focused sleep-diagnostic hardware-and-software vendor competing for the same home/ambulatory PSG use case.
  • Compumedics: Australasian sleep-diagnostics and neurology company offering Somfit, Somte, and Profusion polysomnography platforms. Comparable as a dedicated sleep/neuro diagnostics vendor with both hardware sensors and cloud-style analysis software, similar in product mix to Biologix.
  • CleveMed: US-based maker of the SleepView and Sapphire PSG home sleep testing devices with cloud review software. Comparable to Biologix as a focused home-sleep-diagnostic hardware-plus-cloud-software vendor serving the same physician specialties.
  • SOMNOmedics: German manufacturer of home/ambulatory polysomnography systems (SOMNOwatch, SOMNOscreen) used by sleep specialists and researchers. Comparable to Biologix in the home-multimodal-PSG category with proprietary hardware and analysis software.
  • Cadwell Industries: US neurodiagnostics and sleep company selling PSG hardware and cloud review software to sleep labs and clinicians. Comparable to Biologix as a specialist sleep/neurodiagnostics vendor combining proprietary sensors with cloud analytics.

Regional players

  • BMC Medical: Chinese sleep-and-respiratory vendor selling home sleep testing devices, CPAP, and ventilators across Asia and emerging markets. Comparable to Biologix as a regional incumbent pushing into price-sensitive markets with bundled sleep-care hardware.
  • Apex Medical: Taiwan-based sleep-and-respiratory manufacturer offering home sleep testing devices alongside CPAP/BPAP. Comparable to Biologix as an Asia-rooted competitor with multi-channel GTM in emerging markets that could overlap with Latam expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Biologix social profiles

Digital presence

Biologix compliance and trust

Trust signal

Compliance1 record

Biologix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biologix leadership team

Management profile

Number of profiles

Profiles7 records

Biologix funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biologix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biologix

What does Biologix do?

Biologix operates a vertically integrated home sleep apnea diagnostics platform that combines proprietary medical hardware (Oxistar® 2 finger oximetry sensor and Bodystar® body position sensor), a patient-facing mobile app, and a cloud-based clinician portal. The flagship Biologix Sleep Test (Exame do Sono Biologix®) is a multimodal home polysomnography that fuses SpO2, heart rate, actigraphy, and snoring into an AI-driven report (Laudo Automatizado), delivered through a network of 9,000+ accredited diagnostic centers across Latin America.

Is Biologix a public or private company?

Biologix is a private company. It is classified as venture growth investor backed and is currently operating.

When was Biologix founded?

Biologix was founded in 2015. It employs 51 to 100 people.

Where is Biologix based?

Biologix is headquartered in São Paulo, Brazil, in the Latin America region.

How does Biologix make money?

Four revenue lines are on record. Hardware sales — Oxistar® 2 and Bodystar® sensors are the primary driver. The others are per-exam diagnostic service for accredited centers, subscription / portal plans for prescribing professionals and distributor / channel revenue.

Who are Biologix's main competitors?

Broad incumbents on record are Resmed and Philips (Respironics). Direct peers are Itamar Medical (ZOLL Itamar), Nox Medical, Compumedics, CleveMed, SOMNOmedics and Cadwell Industries. Regional players are BMC Medical and Apex Medical.

Does Biologix have an API?

No public API is recorded for Biologix.

What industry is Biologix in?

Biologix's product category is Home Sleep Diagnostics. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLALAFAB, Respiratory & Sleep RPM (COPD, asthma, sleep apnea). Its NAICS code is 6215 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pegnDo colchão à IA: a economia do sono cria novos negócios e acelera no BrasilA growing sleep economy in Brazil is driving the creation of new businesses across sectors including interior design, digital therapy, home diagnostics, and wellness services, with 31% of the population in capital cities reporting insomnia symptoms according to Vigitel 2025. Multiple Brazilian startups are scaling rapidly: digital therapy platform Vigilantes by Galileu projects revenue to exceed R$10 million in 2026 following its acquisition by Galileu Saúde, while home diagnostics company Biologix expects to reach R$24 million, and interior design studio Marcela Aquino aims for R$450,000 in revenue. The trend reflects a broader shift in consumer behavior, with sleep increasingly viewed as an investment in productivity rather than a luxury.HrtodayJoëlle Massaad Appointed as Head of People & Culture at Algorithm Pharmaceutical Manufacturers & BiologixJoëlle Massaad has been appointed Head of People & Culture at Algorithm Pharmaceutical Manufacturers & Biologix, a dual leadership role covering both pharmaceutical companies operating across the MENA region. Massaad previously spent over five years at Unilever in senior HR positions including Head of HR Unilever Levant & Iraq, and brings additional experience from roles at Zaatar W Zeit, Caritas Lebanon, Zimmer Biomet, and Procter & Gamble. Algorithm Pharmaceutical Manufacturers focuses on licensed products and differentiated generics in therapeutic areas such as cardio-metabolic health and neurology, while Biologix specializes in bringing innovative drugs from multinational manufacturers to the MENA market through its network of over 17 strategic locations.NatureValidation of an overnight wireless high-resolution oximeter for the diagnosis of obstructive sleep apnea at homeA study validated a wireless high-resolution oximeter (Biologix) against a home sleep test in 478 patients with suspected obstructive sleep apnea. The oximeter's oxygen desaturation index showed high diagnostic accuracy, with AUCs of 0.983, 0.986, and 0.990 for mild, moderate-to-severe, and severe OSA, respectively. The device's variability was lower than night-to-night home test variability.EretzConheça a parceria entre Einstein e a startup Biologix para melhorar o sono das pessoasA parceria entre o Hospital Israelita Albert Einstein e a startup Biologix iniciou um projeto para monitoramento do sono e diagnóstico de apneia obstrutiva usando um oxímetro portátil. O dispositivo, que será oferecido aos pacientes do Einstein, fornece dados detalhados de saturação de oxigênio e frequência cardíaca durante o sono, ajudando na identificação e tratamento do distúrbio.